Call to prioritise nanomedicine:
This article was originally published in Clinica
Nanomedicine is a valuable new technology for diagnostics and should have a higher profile in medicine, according to influential medical journal The Lancet. The statement in its August 30 2003 issue follows a review of nanoscience by the US National Institutes of Health (NIH), which highlighted disease diagnosis and treatment as key areas in which the discipline could help mankind. According to NIH, nanostructures (defined as between 1-100nm in size) offer "novel means for body or organ imaging. Nanotweezers and surgical tools only a few nanometers thick are already in development. Nanoprobes may be able to add diagnostic specificity to biopsy studies."
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.